{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05259072",
            "orgStudyIdInfo": {
                "id": "00023310"
            },
            "organization": {
                "fullName": "Oregon Health and Science University",
                "class": "OTHER"
            },
            "briefTitle": "carDIo-ttranSSfOrm nucLEar Imaging Study",
            "officialTitle": "carDIo-ttranSSfOrm nucLEar Imaging Study",
            "acronym": "DISSOLvE",
            "therapeuticArea": [
                "Cardiovascular",
                "Other"
            ],
            "study": "cardio-ttranssform-nuclear-imaging-study"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-01-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-02-17",
            "studyFirstSubmitQcDate": "2022-02-17",
            "studyFirstPostDateStruct": {
                "date": "2022-02-28",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-02-17",
            "lastUpdatePostDateStruct": {
                "date": "2022-02-28",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Oregon Health and Science University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Ionis Pharmaceuticals, Inc.",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The investigators will evaluate the change in myocardial uptake of 99m-technetium pyrophosphate (Tc-99m PYP) tracer on serial planar and SPECT imaging in patients enrolled in the CARDIO-TTRansform clinical trial (NCT04136171).",
            "detailedDescription": "This is a multicenter trial of 80 subjects enrolled in the CARDIO-TTRansform randomized clinical trial (NCT04136171) who will undergo baseline and follow up Tc-99m PYP to assess for the change in myocardial uptake of the tracer."
        },
        "conditionsModule": {
            "conditions": [
                "Amyloidosis",
                "Transthyretin Amyloid Cardiomyopathy"
            ],
            "keywords": [
                "pyrophosphate scintigraphy",
                "bone scintigraphy",
                "eplontersen",
                "tafamidis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 80,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Patients with transthyretin amyloid cardiomyopathy enrolled in CARDIO-TTRansform",
                    "type": "OTHER",
                    "description": "Patients will undergo serial Tc-99m PYP imaging at baseline, week 61 and end of trial",
                    "interventionNames": [
                        "Diagnostic Test: 99m-technetium pyrophosphate scintigraphy"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "99m-technetium pyrophosphate scintigraphy",
                    "description": "Imaging test",
                    "armGroupLabels": [
                        "Patients with transthyretin amyloid cardiomyopathy enrolled in CARDIO-TTRansform"
                    ],
                    "otherNames": [
                        "Tc-99m PYP"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Primary outcome",
                    "description": "Percentage of patients in both treatment groups with an improvement in the semi-quantitative visual grade by at least 1 grade from baseline and an improvement in the heart/contralateral ratio by at least 20% from baseline to end of treatment.",
                    "timeFrame": "120-140 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Secondary outcome",
                    "description": "Change in cardiac amyloid activity on Tc-99m PYP SPECT as quantified by the target to background ratio from baseline to end of treatment",
                    "timeFrame": "120-140 weeks"
                },
                {
                    "measure": "Secondary outcome",
                    "description": "Percentage of patients in both treatment groups with an improvement in the semi-quantitative visual grade by at least 1 grade from baseline and an improvement in the heart/contralateral ratio by at least 20% from baseline to week 61",
                    "timeFrame": "61 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who were screened and eligible to be enrolled or have been already enrolled in the CARDIO-TTRansform randomized clinical trial (NCT04136171) and have a baseline 99m-technetium pyrophosphate planar and SPECT imaging done within 12 months prior to screening for CARDIO-TTRansform.\n* Patients have to meet the inclusion and exclusion criteria of CARDIO-TTRansform trial to be enrolled.\n* Patient willing to consent for the study and undergo the study procedures.\n\nExclusion Criteria:\n\n* None",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "60 Years",
            "maximumAge": "90 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ahmad Masri, MD MS",
                    "role": "CONTACT",
                    "phone": "503-494-8582",
                    "email": "masria@ohsu.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Ahmad Masri, MD MS",
                    "affiliation": "Oregon Health and Science University",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "Oregon Health & Science University",
                    "status": "RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97239",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ahmad Masri, MD",
                            "role": "CONTACT",
                            "phone": "503-494-8582",
                            "email": "masria@ohsu.edu"
                        },
                        {
                            "name": "Ahmad Masri, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009202",
                    "term": "Cardiomyopathies"
                },
                {
                    "id": "D000000686",
                    "term": "Amyloidosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000057165",
                    "term": "Proteostasis Deficiencies"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4021",
                    "name": "Amyloidosis",
                    "asFound": "Amyloidosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12154",
                    "name": "Cardiomyopathies",
                    "asFound": "Cardiomyopathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M28747",
                    "name": "Proteostasis Deficiencies",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                }
            ]
        }
    },
    "hasResults": false
}